Disclaimer

Disclaimer


This Disclaimer governs your access to web sites controlled by Rigel Pharmaceuticals, Inc. (“Rigel”) located at www.rigel.com, www.tavalisse.com, eap.rigel.com, and any other websites controlled by Rigel that link to this Disclaimer (collectively, “Site”). The contents of this Site are owned or controlled by Rigel. All contents of the Site are protected by worldwide copyright laws. The trademarks, service marks, trade names, and trade dress on this Site are protected both in the United States and internationally. No use of any of these may be made without the prior written authorization of Rigel. Identification should be in the proper format according to local statutes and rules. Individuals may download content for personal use only. No modification or further reproduction of the contents is permitted. The contents may otherwise not be copied or used in any way.

Rigel will use reasonable efforts to keep information in this Site current and accurate, but the company makes no representations, warranties, or assurances as to the accuracy, currency, or completeness of the information provided. In addition, Rigel makes no representations, warranties, or assurances that access to this Site will be uninterrupted, timely, secure, or that the Site will be free from defects or that any such defects will be promptly remediated or fully corrected. Rigel shall not be liable for any damages or injury resulting from anyone's ability to access, or inability to access, this Site, or from anyone's reliance on any information provided at this Site. Any hyperlinks from this Site or references to other web sites for which Rigel has no control over content shall be the responsibility of the user. Any links to other web sites are provided as merely a convenience to the users of this Site. Rigel shall not be liable for any damages or injury arising from the content of such web sites.

Communications you send to Rigel by electronic mail are treated as confidential, and Rigel will not generally use or publicly disclose the content of any such communications, including any ideas, inventions, concepts, techniques, or know-how disclosed therein, for developing, manufacturing, and/or marketing goods or services. Any personally identifiable information you share with Rigel through electronic mail will be governed by our Site’s Privacy Policy. The sender of any communications to this Site or otherwise to Rigel shall be responsible for the content and information contained therein, including its truthfulness and accuracy.

While there may be information on this Site regarding our pharmaceutical products and related medical conditions and/or their treatment, this Site is intended for informational purposes only and should not be treated as a substitute for advice, diagnosis or treatment of a medical condition by a qualified health care professional. Rigel does not provide medical advice, diagnosis or treatment services. If you have a medical condition or questions related to your health, please consult with a qualified health care professional.

This Site contains statements indicating expectations about future performance and other forward-looking statements that involve risks and uncertainties. We usually use words such as "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "intend," or the negative of these terms or similar expressions to identify these forward-looking statements. These statements appear throughout this website and are statements regarding our current expectation, belief or intent, primarily with respect to our operations and related industry developments. Examples of these statements include, but are not limited to, statements regarding the following: our business and scientific strategies; the progress of our product development programs, including clinical testing, and the timing of results thereof; our corporate collaborations and revenues that may be received from our collaborations; our drug discovery technologies; our research and development expenses; protection of our intellectual property; sufficiency of our cash resources; and our operations and legal risks. You should not place undue reliance on these forward-looking statements. There are a number of important factors that could cause Rigel's plans to differ materially from those indicated by these forward-looking statements, including risks associated with the timing of clinical trials, as well as other risks, detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Annual Reports on Form 10-K and its Quarterly Reports on Form 10-Q, available on or through this Site. We undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.